Micro molecular testing

Ended Purchase Order Awarded Last action

Contract number
36C24825P1029
Awardee
Awarding agency
Obligated
$707,439

Award facts

Opportunity
Contract value 27% obligated
  • $707,438.96 Current, with exercised options
  • $2,650,435.95 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Sunnyvale, CA 94089, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 -$139,160
Other Administrative Action P00001 $564,399
Original award $282,200

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a $2.65M firm fixed-price purchase order to Cepheid Inc. for micro molecular testing equipment and supplies on April 1, 2025, with an ultimate completion date of September 30, 2029. The contract covers diagnostic testing kits and laboratory equipment for the West Palm Beach VA Hospital, including molecular diagnostic assays such as GXCDIFF/EPI-10, GXMRSA-NXG-10, CT/NG testing kits, and XPRS4PLEX-10 reagents, along with associated equipment including instrument leases, printers, and uninterruptible power supplies. As an Authorized Distributor, Cepheid is providing these solutions from its existing inventory with a 10-day delivery requirement. No set-aside designation was used for this procurement.

Cepheid is a Sunnyvale, California-based manufacturer of molecular diagnostic solutions with an established track record serving federal healthcare systems. The company holds substantial IDV contracts with the VA, including a $32.8M single-award vehicle with Veterans Integrated Service Network 6 for molecular diagnostic testing reagents and assays, and a $2.5M contract with Veterans Integrated Service Network 21 for PCR laboratory testing. Cepheid's product portfolio specializes in detecting infectious diseases and clinical conditions including COVID-19, influenza, RSV, and MRSA through its GeneXpert diagnostic systems and associated testing reagents, making it well-positioned to support the VA's ongoing molecular diagnostics requirements across multiple service networks.

Quick answers

Who was awarded contract 36C24825P1029?

36C24825P1029 was awarded to Cepheid by Veterans Integrated Service Network 8 (Veterans Health Administration) on April 1, 2025.

How much is contract 36C24825P1029 worth?

The government has obligated $707,439 on 36C24825P1029. Its potential value, with all options, is $2,650,436.

Was contract 36C24825P1029 competed?

The extent of competition for 36C24825P1029 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award